Company profile: Codiak BioSciences
1.1 - Company Overview
Company description
- Provider of pioneering development of exosome-based therapeutics as a clinical-stage biopharmaceutical company.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Codiak BioSciences
Eclipse Therapeutics
HQ: United States
Website
- Description: Provider of therapeutics discovery and development targeting cancer stem cells (CSCs) and other innovative cancer treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eclipse Therapeutics company profile →
Cell Pathways
HQ: United States
Website
- Description: Provider of small molecule-based drugs for cancer treatment leveraging an apoptosis technology platform, which can be used with other chemotherapy drugs, and of kits and methods for detection and quantification, including PCR ED ELISA kits for DIG-labeled PCR products, Endothelin-1 ELISA kits for multiple species, and combined PCR-ELISA nucleic acid detection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cell Pathways company profile →
Light Chain Bio
HQ: Switzerland
Website
- Description: Provider of research and development of novel multi-specific antibodies that rely on their light chain for their function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Light Chain Bio company profile →
AvenCell Therapeutics
HQ: United States
Website
- Description: Provider of switchable and allogeneic CAR-T cell therapy platforms, including a Universal Switchable CAR with soluble targeting modules for hematologic malignancies and solid tumors; a CRISPR/Cas9-based platform enabling off-the-shelf CAR-T that overcomes graft-versus-host disease and immune rejection; and therapies AVC-101 (CD123 autologous) and AVC-201 (allogeneic UniCAR) for relapsed/refractory AML.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AvenCell Therapeutics company profile →
HistoSonics
HQ: United States
Website
- Description: Provider of non-invasive medical devices and technologies for interventional radiology and surgical robotics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HistoSonics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Codiak BioSciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Codiak BioSciences
2.2 - Growth funds investing in similar companies to Codiak BioSciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Codiak BioSciences
4.2 - Public trading comparable groups for Codiak BioSciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →